Cite
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium
MLA
Ola, Landgren, et al. “Flow Cytometry Detection of Minimal Residual Disease in Multiple Myeloma: Lessons Learned at FDA-NCI Roundtable Symposium.” American Journal of Hematology, vol. 89, no. 12, Aug. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c2a6ee72249b1ba04a16576e899a36a1&authtype=sso&custid=ns315887.
APA
Ola, L., Nicole, G., Danielle, T., Roger G, O., Andy, R., Bruno, P., David, B., Maria, A., Paul, W., Brian, D., Constance, Y., Ahmet, D., Maryalice, S.-S., & Gerald E, M. (2014). Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. American Journal of Hematology, 89(12).
Chicago
Ola, Landgren, Gormley Nicole, Turley Danielle, Owen Roger G, Rawstron Andy, Paiva Bruno, Barnett David, et al. 2014. “Flow Cytometry Detection of Minimal Residual Disease in Multiple Myeloma: Lessons Learned at FDA-NCI Roundtable Symposium.” American Journal of Hematology 89 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c2a6ee72249b1ba04a16576e899a36a1&authtype=sso&custid=ns315887.